TransMedics Group (STU:TMDX) EV-to-EBIT : 3,817.58 (As of May. 15, 2024)

View and export this data going back to 2023. Start your Free Trial

What is TransMedics Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, TransMedics Group's Enterprise Value is €4,195.5 Mil. TransMedics Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €1.1 Mil. Therefore, TransMedics Group's EV-to-EBIT for today is 3,817.58.

The historical rank and industry rank for TransMedics Group's EV-to-EBIT or its related term are showing as below:

STU:TMDX' s EV-to-EBIT Range Over the Past 10 Years
Min: -236.22 Med: -22.21 Max: 2884.51
Current: 2746.83

During the past 8 years, the highest EV-to-EBIT of TransMedics Group was 2884.51. The lowest was -236.22. And the median was -22.21.

STU:TMDX's EV-to-EBIT is ranked worse than
99.78% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.815 vs STU:TMDX: 2746.83

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. TransMedics Group's Enterprise Value for the quarter that ended in Mar. 2024 was €2,468.7 Mil. TransMedics Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €1.1 Mil. TransMedics Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 0.04%.

TransMedics Group EV-to-EBIT Historical Data

The historical data trend for TransMedics Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TransMedics Group EV-to-EBIT Chart

TransMedics Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-12.22

-18.19

-12.00

-57.03

-170.02

TransMedics Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															-95.82	-216.60	-64.59	-170.02	1,577.53

Competitive Comparison of TransMedics Group's EV-to-EBIT

For the Medical Devices subindustry, TransMedics Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TransMedics Group's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where TransMedics Group's EV-to-EBIT falls into.

TransMedics Group EV-to-EBIT Calculation

TransMedics Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	4195.515	/	1.099
	=	3,817.58

TransMedics Group's current Enterprise Value is €4,195.5 Mil.
TransMedics Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.1 Mil.

TransMedics Group (STU:TMDX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

TransMedics Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	1.099	/	2468.7487
	=	0.04 %

TransMedics Group's Enterprise Value for the quarter that ended in Mar. 2024 was €2,468.7 Mil.
TransMedics Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.1 Mil.

TransMedics Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of TransMedics Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

TransMedics Group (STU:TMDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » TransMedics Group Inc (STU:TMDX) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

TMDX:USA 8T8:Germany

Address

200 Minuteman Road, Andover, MA, USA, 01810

Website

https://www.transmedics.com

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.